Related references
Note: Only part of the references are listed.Physiologically Based Pharmacokinetic Modeling of Central Nervous System Pharmacokinetics of CDK4/6 Inhibitors to Guide Selection of Drug and Dosing Regimen for Brain Cancer Treatment
Jing Li et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
Abundance of P-Glycoprotein and Other Drug Transporters at the Human Blood-Brain Barrier in Alzheimer's Disease: A Quantitative Targeted Proteomic Study
Flavia Storelli et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
Impact of CNS Diseases on Drug Delivery to Brain Extracellular and Intracellular Target Sites in Human: A WHAT-IF Simulation Study
Mohammed A. A. Saleh et al.
PHARMACEUTICS (2021)
A physiologically-based pharmacokinetic model to describe antisense oligonucleotide distribution after intrathecal administration
Michael Monine et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2021)
Translational CNS Steady-State Drug Disposition Model in Rats, Monkeys, and Humans for Quantitative Prediction of Brain-to-Plasma and Cerebrospinal Fluid-to-Plasma Unbound Concentration Ratios
Sho Sato et al.
AAPS JOURNAL (2021)
Lumbar cerebrospinal fluid-to-brain extracellular fluid surrogacy is context-specific: insights from LeiCNS-PK3.0 simulations
Mohammed A. A. Saleh et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2021)
LightBBB: computational prediction model of blood-brain-barrier penetration based on LightGBM
Bilal Shaker et al.
BIOINFORMATICS (2021)
Opening a debate on open-source modeling tools: Pouring fuel on fire versus extinguishing the flare of a healthy debate
Amin Rostami-Hodjegan et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2021)
Developmental changes in transporter and receptor protein expression levels at the rat blood-brain barrier based on quantitative targeted absolute proteomics
Kotaro Omori et al.
DRUG METABOLISM AND PHARMACOKINETICS (2020)
Protein Expression and Functional Relevance of Efflux and Uptake Drug Transporters at the Blood-Brain Barrier of Human Brain and Glioblastoma
Xun Bao et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
The endless frontier? The recent increase of R&D productivity in pharmaceuticals
Fabio Pammolli et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
Comparison of Absolute Protein Abundances of Transporters and Receptors among Blood-Brain Barriers at Different Cerebral Regions and the Blood-Spinal Cord Barrier in Humans and Rats
Yasuo Uchida et al.
MOLECULAR PHARMACEUTICS (2020)
A 3D brain unit model to further improve prediction of local drug distribution within the brain
Esmee Vendel et al.
PLOS ONE (2020)
Quantitative Systems Pharmacology for Neuroscience Drug Discovery and Development: Current Status, Opportunities, and Challenges
Hugo Geerts et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2020)
Interindividual and Regional Variability in Drug Transporter Abundance at the Human Blood-Brain Barrier Measured by Quantitative Targeted Proteomics
Sarah Billington et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
LC-MS/MS-based quantification of efflux transporter proteins at the BBB
David Gomez-Zepeda et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2019)
Proteomic Quantification of Human Blood-Brain Barrier SLC and ABC Transporters in Healthy Individuals and Dementia Patients
Zubida M. Al-Majdoub et al.
MOLECULAR PHARMACEUTICS (2019)
Model-Informed Drug Development: Current US Regulatory Practice and Future Considerations
Yaning Wang et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Prediction of human CNS pharmacokinetics using a physiologically-based pharmacokinetic modeling approach
Yumi Yamamoto et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Identification and quantification of blood-brain barrier transporters in isolated rat brain microvessels
Hajar Al Feteisi et al.
JOURNAL OF NEUROCHEMISTRY (2018)
Development of a Region-Specific Physiologically Based Pharmacokinetic Brain Model to Assess Hippocampus and Frontal Cortex Pharmacokinetics
Zaril Zakaria et al.
PHARMACEUTICS (2018)
Preclinical QSP Modeling in the Pharmaceutical Industry: An IQ Consortium Survey Examining the Current Landscape
Marjoleen J. M. A. Nijsen et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2018)
Reverse Translation in PBPK and QSP: Going Backwards in Order to Go Forward With Confidence
Amin Rostami-Hodjegan
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
A Generic Multi-Compartmental CNS Distribution Model Structure for 9 Drugs Allows Prediction of Human Brain Target Site Concentrations
Yumi Yamamoto et al.
PHARMACEUTICAL RESEARCH (2017)
Targeted unlabled multiple reaction monitoring analysis of cell markers for the study of sample heterogeneity in isolated rat brain cortical microvessels
David Gomez-Zepeda et al.
JOURNAL OF NEUROCHEMISTRY (2017)
Predicting Drug Concentration-Time Profiles in Multiple CNS Compartments Using a Comprehensive Physiologically-Based Pharmacokinetic Model
Yumi Yamamoto et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2017)
Quantitative Modeling and Simulation in PMDA: A Japanese Regulatory Perspective
M. Sato et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2017)
Microdialysis: the Key to Physiologically Based Model Prediction of Human CNS Target Site Concentrations
Yumi Yamamoto et al.
AAPS JOURNAL (2017)
Translational Modeling in Schizophrenia: Predicting Human Dopamine D2 Receptor Occupancy
Martin Johnson et al.
PHARMACEUTICAL RESEARCH (2016)
Development of a permeability-limited model of the human brain and cerebrospinal fluid (CSF) to integrate known physiological and biological knowledge: Estimating time varying CSF drug concentrations and their variability using in vitro edata
Lu Gaohua et al.
DRUG METABOLISM AND PHARMACOKINETICS (2016)
A new PAMPA model using an in-house brain lipid extract for screening the blood-brain barrier permeability of drug candidates
Joana Bicker et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)
Good Practices in Model-Informed Drug Discovery and Development: Practice, Application, and Documentation
S. F. Marshall et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2016)
A balanced view of choroid plexus structure and function: Focus on adult humans
Reynold Spector et al.
EXPERIMENTAL NEUROLOGY (2015)
Combining the 'bottom up' and 'top down' approaches in pharmacokinetic modelling: fitting PBPK models to observed clinical data
Nikolaos Tsamandouras et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Comparing translational population-PBPK modelling of brain microdialysis with bottom-up prediction of brain-to-plasma distribution in rat and human
Kathryn Ball et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2014)
A Method to Predict Blood-Brain Barrier Permeability of Drug-Like Compounds Using Molecular Dynamics Simulations
Timothy S. Carpenter et al.
BIOPHYSICAL JOURNAL (2014)
Using Positron Emission Tomography to Study Transporter-Mediated Drug-Drug Interactions in Tissues
B. Wulkersdorfer et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
Prediction of methotrexate CNS distribution in different species - Influence of disease conditions
Joost Westerhout et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
A Physiologically Based Modeling Strategy during Preclinical CNS Drug Development
Kathryn Ball et al.
MOLECULAR PHARMACEUTICS (2014)
Development of a Physiologically-Based Pharmacokinetic Model of the Rat Central Nervous System
Raj Badhan et al.
Pharmaceutics (2014)
Quantitative Atlas of Blood-Brain Barrier Transporters, Receptors, and Tight Junction Proteins in Rats and Common Marmoset
Yutaro Hoshi et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
The impact of P-gp functionality on non-steady state relationships between CSF and brain extracellular fluid
Joost Westerhout et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2013)
Does size matter in R&D productivity? If not, what does?
Michael Ringel et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Physiologically Based Pharmacokinetic Modeling to Investigate Regional Brain Distribution Kinetics in Rats
Joost Westerhout et al.
AAPS JOURNAL (2012)
Blood-brain barrier P-glycoprotein function in Alzheimer's disease
Danielle M. E. van Assema et al.
BRAIN (2012)
Physiologically Based Pharmacokinetics Joined With In Vitro-In Vivo Extrapolation of ADME: A Marriage Under the Arch of Systems Pharmacology
A. Rostami-Hodjegan
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Overview and introduction: The blood-brain barrier in health and disease
N. Joan Abbott et al.
EPILEPSIA (2012)
Comparison of brain capillary endothelial cell-based and epithelial (MDCK-MDR1, Caco-2, and VB-Caco-2) cell-based surrogate blood-brain barrier penetration models
Eve Hellinger et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2012)
Development of a physiologically based pharmacokinetic model for the rat central nervous system and determination of an in vitro-in vivo scaling methodology for the blood-brain barrier permeability of two transporter substrates, morphine and oxycodone
Kathryn Ball et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Exploratory Translational Modeling Approach in Drug Development to Predict Human Brain Pharmacokinetics and Pharmacologically Relevant Clinical Doses
W. Kielbasa et al.
DRUG METABOLISM AND DISPOSITION (2012)
The MDCK variety pack: choosing the right strain
Joseph D. Dukes et al.
BMC CELL BIOLOGY (2011)
Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors
Yasuo Uchida et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Transcriptomic and Quantitative Proteomic Analysis of Transporters and Drug Metabolizing Enzymes in Freshly Isolated Human Brain Microvessels
Ramzi Shawahna et al.
MOLECULAR PHARMACEUTICS (2011)
Targeting blood-brain barrier changes during inflammatory pain: an opportunity for optimizing CNS drug delivery
Patrick T. Ronaldson et al.
THERAPEUTIC DELIVERY (2011)
Development of a High-Throughput Brain Slice Method for Studying Drug Distribution in the Central Nervous System
Markus Friden et al.
DRUG METABOLISM AND DISPOSITION (2009)
Assessing drug distribution in tissues expressing P-glycoprotein through physiologically based pharmacokinetic modeling: model structure and parameters determination
Frederique Fenneteau et al.
THEORETICAL BIOLOGY AND MEDICAL MODELLING (2009)
Pharmacokinetic modeling of non-linear brain distribution of fluvoxamine in the rat
Marian Geldof et al.
PHARMACEUTICAL RESEARCH (2008)
Benchmarking of QSAR models for blood-brain barrier permeation
Dmitry A. Konovalov et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2007)
Population pharmacokinetic modelling of non-linear brain distribution of morphine: influence of active saturable influx and P-glycoprotein mediated efflux
D. Groenendaal et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Expression of drug transporters at the blood-brain barrier using an optimized isolated rat brain microvessel strategy
Salah Yousif et al.
BRAIN RESEARCH (2007)
Carrier-mediated processes at several rat brain interfaces determine the neuropharmacokinetics of morphine and morphine-6-β-D-glucuronide
F Bourasset et al.
LIFE SCIENCES (2006)
QSAR Studies on Blood-Brain Barrier Permeation
Juan M. Luco et al.
CURRENT COMPUTER-AIDED DRUG DESIGN (2006)
Use of a physiologically based pharmacokinetic model to study the time to reach brain equilibrium: An experimental analysis of the role of blood-brain barrier permeability, plasma protein binding, and brain tissue binding
XR Liu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Development of a computational approach to predict blood-brain barrier permeability
XR Liu et al.
DRUG METABOLISM AND DISPOSITION (2004)
High throughput artificial membrane permeability assay for blood-brain barrier
L Di et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2003)
Influence of nonspecific brain and plasma binding on CNS exposure: Implications for rational drug discovery
JC Kalvass et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2002)
Share Paper
